TY - JOUR
T1 - Defining research and infrastructure priorities for cancer survivorship in Australia
T2 - a modified Delphi study
AU - Crawford-Williams, Fiona
AU - Koczwara, Bogda
AU - Chan, Raymond J.
AU - Vardy, Janette
AU - Lisy, Karolina
AU - Morris, Julia
AU - Iddawela, Mahesh
AU - Mackay, Gillian
AU - Jefford, Michael
PY - 2022/5
Y1 - 2022/5
N2 - Purpose: The aim of this study was to establish research and infrastructure priorities for cancer survivorship. Methods: A two-round modified online Delphi study was completed by Australian experts in cancer survivorship. Initial priorities were generated from the literature and organized into four research categories: physiological outcomes, psychosocial outcomes, population groups, and health services; and one research infrastructure category. In round 1 (R1), panelists ranked the importance of 77 items on a five-point scale (not at all important to very important). In round 2 (R2), panelists ranked their top 5 priorities within each category. Panelists also specified the type of research needed, such as biological, exploratory, intervention development, or implementation, for the items within each research category. Results: Response rates were 76% (63/82) and 82% (68/82) respectively. After R1, 12 items were added, and 16 items combined or reworded. In R2, the highest prioritized research topics and the preferred type of research in each category were: biological research in cancer progression and recurrence; implementation and dissemination research for fear of recurrence; exploratory research for rare cancer types; and implementation research for quality of care topics. Data availability was listed as the most important priority for research infrastructure. Conclusions: This study has defined priorities that can be used to support coordinated action between researchers, funding bodies, and other key stakeholders. Designing future research which addresses these priorities will expand our ability to meet survivors’ diverse needs and lead to improved outcomes.
AB - Purpose: The aim of this study was to establish research and infrastructure priorities for cancer survivorship. Methods: A two-round modified online Delphi study was completed by Australian experts in cancer survivorship. Initial priorities were generated from the literature and organized into four research categories: physiological outcomes, psychosocial outcomes, population groups, and health services; and one research infrastructure category. In round 1 (R1), panelists ranked the importance of 77 items on a five-point scale (not at all important to very important). In round 2 (R2), panelists ranked their top 5 priorities within each category. Panelists also specified the type of research needed, such as biological, exploratory, intervention development, or implementation, for the items within each research category. Results: Response rates were 76% (63/82) and 82% (68/82) respectively. After R1, 12 items were added, and 16 items combined or reworded. In R2, the highest prioritized research topics and the preferred type of research in each category were: biological research in cancer progression and recurrence; implementation and dissemination research for fear of recurrence; exploratory research for rare cancer types; and implementation research for quality of care topics. Data availability was listed as the most important priority for research infrastructure. Conclusions: This study has defined priorities that can be used to support coordinated action between researchers, funding bodies, and other key stakeholders. Designing future research which addresses these priorities will expand our ability to meet survivors’ diverse needs and lead to improved outcomes.
KW - Cancer research
KW - Cancer survivorship
KW - Delphi study
KW - Research prioritization
UR - http://www.scopus.com/inward/record.url?scp=85123194308&partnerID=8YFLogxK
U2 - 10.1007/s00520-021-06744-2
DO - 10.1007/s00520-021-06744-2
M3 - Article
AN - SCOPUS:85123194308
SN - 0941-4355
VL - 30
SP - 3805
EP - 3815
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 5
ER -